123 filings
Page 2 of 7
8-K
966cvz5c5z289
13 Dec 22
Wave receives upfront payment of $170 million in cash and equity, also eligible to receive milestone payments and royalties
7:48am
8-K
v7awype tyz
15 Nov 22
Regulation FD Disclosure
8:31am
8-K
gd6i0 ddmmu
10 Nov 22
Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
7:35am
8-K
df37sakszro8 c2
4 Oct 22
Regulation FD Disclosure
7:35am
8-K
hppc9ymjrt9mt8m l3
28 Sep 22
Regulation FD Disclosure
1:42pm
8-K
hw6gsqjk
26 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
0tkk2gjwmetkdsnp7dh
20 Sep 22
Regulation FD Disclosure
7:34am
8-K
2fv3k3vedd08
17 Aug 22
Regulation FD Disclosure
4:31pm
8-K
iso7of
15 Aug 22
Departure of Directors or Certain Officers
5:53pm
8-K
79mw 11h00ykmj
11 Aug 22
Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
7:36am
8-K
oczlkcalb
14 Jun 22
Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
9:32am
8-K
2wgw3r6opaoh
12 May 22
Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
7:40am
8-K
g1m2r
4 Apr 22
Reductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses
7:35am
8-K
ebt26b7
3 Mar 22
Entry into a Material Definitive Agreement
4:03pm
8-K
n4wjyhf7 oa
3 Mar 22
Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
7:37am
8-K
sa6tbrfu848i1upy
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
cylboawyx bkc0c8nx
10 Nov 21
Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
7:36am
8-K
8uega1cdfyyqhyexluo
18 Oct 21
Entry into a Material Definitive Agreement
5:06pm
8-K
dq7p7c xg1l
28 Sep 21
Regulation FD Disclosure
4:11pm
8-K
xc38cmx8 dh7kvwsy
10 Sep 21
Regulation FD Disclosure
7:31am